Table 1.
The relationship of VM and clinicopathological data in invasive breast cancer
| Clinicopathological parameters | VM formation | VM positive rate (%) | P value | |
|---|---|---|---|---|
| Positive (n = 27) | Negative (n = 93) | |||
| Age (years) | 47.30 ± 0.62 | 47.67 ± 0.25 | 0.600 | |
| Nodal status | 0.027 | |||
| Positive | 16 | 33 | 32.7 | |
| Negative | 11 | 60 | 15.5 | |
| Differentiation grade | 0.456 | |||
| G1 | 10 | 23 | 30.3 | |
| G2 | 7 | 31 | 18.4 | |
| G3 | 10 | 39 | 20.4 | |
| Histological type, | 0.083 | |||
| Ductal NOS | 19 | 80 | 19.2 | |
| Lobular | 8 | 13 | 38.1 | |
| Tumour size (mm) | 24.78 ± 1.03 | 25.06 ± 0.48 | 0.828 | |
| Tumour stage (UICC) | 0.022 | |||
| I | 7 | 52 | 11.9 | |
| II | 16 | 34 | 32.0 | |
| III | 4 | 7 | 36.4 | |
| ERα or PR status | 0.143 | |||
| Positive | 20 | 80 | 20.0 | |
| Negative | 7 | 13 | 35.0 | |
| HER2 status | 0.018 | |||
| 0/+ | 12 | 69 | 14.8 | |
| ++ | 8 | 13 | 38.1 | |
| +++ | 7 | 11 | 38.9 | |